Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
PRTA
#2838
Prothena Corporation plc Ordinary Shares
10.5
8
USD
+2.62%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+2.62%
Aylık Değişim
+14.13%
6 aylık değişim
+4.55%
Yıllık Değişim
+6.98%
Önceki Kapanış
10.3
1
Open
10.5
1
Bid
Ask
Low
10.5
1
High
10.6
5
Hacim
92
Piyasalar
ABD Borsası
Sağlık Hizmetleri
PRTA
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
39.99 M
46.69 M
52.56 M
53.72 M
53.83 M
53.83 M
—
Valuation ratios
Enterprise value
184.87 M
1.73 B
2.1 B
1.45 B
274.12 M
206.57 M
604.6 M
Price to earnings ratio
—
35.8
-21.66
-13.96
-6.1
-2.11
-11.11
Price to sales ratio
—
11.93
42.06
16.76
4.63
21.58
54.79
Price to cash flow ratio
—
25.85
-23.29
-15.32
-4.96
-3.14
-12.72
Price to book ratio
—
5.14
4.07
3.65
1.53
1.83
2.68
Enterprise value to EBITDA ratio
-1.68
23.62
-16.89
-9.12
-2.14
-1.03
-3.85
Profitability ratios
Return on assets %
-0.33
0.11
-0.15
-0.21
-0.22
-0.75
-0.61
Return on equity %
-0.6
0.14
-0.19
-0.26
-0.25
-0.87
-0.73
Return on invested capital %
-891.51
572.42
-866.74
-977.67
-721.49
-1 703.4
-1 546.73
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-5 073.54
35.88
-218.34
-156.1
-96.02
-900.98
-3 549.42
EBITDA margin %
-4 943.79
36.45
-206.57
-130
-79.42
-837.87
-3 267.32
Net margin %
-5 001.98
33.38
-194.09
-120.14
-75.98
-1 024.61
-3 813.19
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
11.58
17.48
14.34
11.24
10.01
7.72
29.01
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.43
0.09
0.17
0.26
0.05
0.06
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.91
-2.3
-2.52
-2.79
-3.04
-3.04
EBIT per share
—
1.49
-2.64
-3.01
-2.39
-3.72
-3.72
EBITDA per share
—
1.51
-2.63
-2.99
-2.38
-3.71
-3.71
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
11.95
15
11.63
8.77
5.71
26.52
Net current asset value per share
—
12.07
15.18
12.01
9.03
5.86
27.44
Tangible book value per share
—
9.62
13.13
10.55
9.06
5.21
24.85
Working capital per share
—
11.38
14.12
10.94
8.13
5.1
23.56
Book value per share
—
9.62
13.13
10.55
9.06
5.21
24.85
Haberler
AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa
Sanofi Gets EU Nod for Rezurock in Chronic Graft-Vs-Host Disease
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
Why Is Sarepta Therapeutics (SRPT) Up 24.2% Since Last Earnings Report?
Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report?
H.C. Wainwright, Parkinson verilerine rağmen Prothena hissesi için tavsiyesini korudu
Citizens, Prothena hissesi için hedef fiyatı teyit etti
Citizens reaffirms Prothena stock rating on Novo Nordisk milestone
Prothena, Novo Nordisk’ten ilaç denemesi için 50 milyon dolar aldı
Prothena earns $50M milestone from Novo Nordisk for drug trial
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade
Prothena hisseleri 100 milyon dolarlık geri alım onayıyla yükseldi